Results 211 to 220 of about 45,700 (265)

Finerenone in heart failure with left ventricular ejection fraction ≥40%: a correspondence. [PDF]

Ann Med Surg (Lond)
Furqan M, Haider MU, Binte Rahim S.
europepmc   +1 more source

Unsupervised machine learning for cardiovascular disease: A framework for future studies

European Journal of Heart Failure, EarlyView.
Unsupervised machine learning can improve the characterization and stratification of patients with cardiovascular diseases (CVDs). Clustering algorithms, which group patients based on patterns in clinical data, can reveal distinct subgroups that may differ in prognosis and treatment response.
Emmanuel Bresso, Claire Lacomblez, Kévin Duarte, Luca Monzo, Guillaume Baudry, Jasper Tromp, Abhinav Sharma, Nicolas Girerd   +7 more
wiley   +1 more source

Pillar Risk-Based Treatment for Chronic Kidney Disease in People With Type 2 Diabetes: A Narrative Review. [PDF]

Diabetes Ther
Cheng AYY, Mottl A, Magwire M.
europepmc   +1 more source

Short‐ and mid‐term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure

European Journal of Heart Failure, EarlyView.
Effects of empagliflozin on sodium and fluid regulation in chronic heart failure (CHF). EF, ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide NYHA, New York Heart Association. Aims Sodium–glucose co‐transporter 2 inhibitors have become a cornerstone in managing chronic heart failure (CHF).
Venera Bytyqi, Dennis Kannenkeril, Julie Kolwelter, Peter Linz, Agnes Bosch, Kristina Striepe, Marina V. Karg, Armin M. Nagel, Michael Uder, Mario Schiffer, Stephan Achenbach, Roland E. Schmieder   +11 more
wiley   +1 more source

Current Application of Mineralocorticoid Antagonist (MRA) in Heart Failure and CKD: Does Non-Steroidal Drug Add Novel Insights. [PDF]

Biomedicines
Carlino I, Pirrotta F, Gennari L, Palazzuoli A.   +3 more
europepmc   +1 more source

Urinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi, Biykem Bozkurt, Peder Langeland Myhre, Juan Carlos Lopez Azor, Mateusz Guzik, Gracjan Iwanek, Guillaume Baudry, Marta Cobo‐Marcos, Òscar Miró, Jeroen Dauw, Piotr Ponikowski, Wilfried Mullens, Alberto Palazzuoli, Marco Metra, Jan Biegus   +14 more
wiley   +1 more source

Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease. [PDF]

Eur Heart J
Kobayashi M, Pitt B, Ferreira JP, Rossignol P, Girerd N, Zannad F.   +5 more
europepmc   +1 more source

Outpatient loop diuretic use and the effect of natriuresis‐guided diuretic therapy: A prespecified sub‐analysis of the PUSH‐AHF study

European Journal of Heart Failure, EarlyView.
The effects of natriuresis‐guided diuretic therapy in patients with acute decompensated heart failure, depending on outpatient loop diuretic use. HR, hazard ratio; NG, natriuresis‐guided; SOC, standard of care. Aims Diuretic resistance is frequently observed in patients with acute decompensated heart failure (ADHF), specifically in those with chronic ...
Lara E.E.C. Zonneveld, Iris E. Beldhuis, Hailun Qin, Dirk J. van Veldhuisen, Jenifer E. Coster, Wybe Nieuwland, Jan A. Krikken, Peter van der Meer, Adriaan A. Voors, Kevin Damman, Jozine M. ter Maaten   +10 more
wiley   +1 more source

Correction to: Clinical implications of mineralocorticoid receptor overactivation. [PDF]

Clin Kidney J
europepmc   +1 more source

Hypertension and hyperkalemia associated with Pro701Leu mutation in the NR3C2 gene: A case report. [PDF]

Medicine (Baltimore)
Kwon L, Griffiths J, Greenberg S, Assante W.   +3 more
europepmc   +1 more source